Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. - Wikidata - awgldk - TriplyDB

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors.

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors.

http://www.wikidata.org/entity/Q40692830

about

Salivary PYY: a putative bypass to satiety Inactivation of Pink1 gene in vivo sensitizes dopamine-producing neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and can be rescued by autosomal recessive Parkinson disease genes, Parkin or DJ-1 Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.Gene therapy rescues cone function in congenital achromatopsia.Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies Hematopoietic- and neurologic-expressed sequence 1 expression in the murine GL261 and high-grade human gliomas Manufacturing of recombinant adeno-associated viral vectors for clinical trials Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's disease Quantitative and semi-quantitative measurements of axonal degeneration in tissue and primary neuron cultures Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation 3D Imaging of Axons in Transparent Spinal Cords from Rodents and Nonhuman Primates(,.)Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment Central overexpression of leptin antagonist reduces wheel running and underscores importance of endogenous leptin receptor activity in energy homeostasis AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia Regulation of ischemic neuronal death by E2F4-p130 protein complexes Massively parallel cis-regulatory analysis in the mammalian central nervous system Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature development Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease Enhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathology Comparative analysis of adeno-associated virus capsid stability and dynamics Treatment of congenital neurotransmitter deficiencies by intracerebral ventricular injection of an adeno-associated virus serotype 9 vector.VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors SCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruption.XIAP protection of photoreceptors in animal models of retinitis pigmentosa.Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9.An adeno-associated viral vector transduces the rat hypothalamus and amygdala more efficient than a lentiviral vector Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo.Neuropeptide delivery to the brain: a von Willebrand factor signal peptide to direct neuropeptide secretion.Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented.

P2860

Q21101917-48C51D20-FE6F-4ADF-B1E5-BD9D8E1E0ABF Q24315046-700C386E-B22C-4392-B6EC-D6062DC3B2AA Q24538483-B03158B0-D811-4CB9-9D6B-11FB3ED01CA4 Q24563214-0BE77912-FF55-479A-B055-59F4E241866C Q24563378-81FA24A0-EDB2-46B6-88D5-A20C99A2C912 Q24595787-7AD0953C-3AB0-4ACA-9122-DDFF6E1084BA Q24608049-F05F1BA4-DF1E-4CFD-A010-916D3A115AEF Q24623859-A22A3F7C-B0B4-4C44-9DC8-89B12968194E Q24630417-5F2FCB49-3792-4446-9193-19EBAA7B8881 Q24650862-D6C96E0F-AC30-41E1-B325-042526F42C58 Q26750799-0D2A62D5-8914-4E5F-8CB8-2A7A2548D4CB Q27318185-283A00EF-C709-4E86-AA90-7E29D96E2E3D Q27318262-3D40D40F-36D1-4BAF-A67B-4EFA6FC71178 Q27334472-B58BAA90-0D8D-456D-B05C-E319E0C32244 Q28364882-0EDB8E8E-CB2D-4AD8-B4A3-07F746EDD3B5 Q28394174-14326498-F545-4D6C-BF41-587357C3C3B1 Q28544842-813C01F9-FDFE-4E7A-AB76-650621ADFFCA Q28547475-231AC681-AA6C-4D66-83F1-CC2ABA7BA31F Q28551718-41E90C04-61AF-4513-A2F9-F33081A55D0C Q28576900-ABF3D70F-4000-4836-A543-FCF8FFB058BE Q28730645-946E8E32-D167-41FC-97C2-561E7ABBC658 Q28771402-0FEE1DF1-F5AC-47EB-9E08-6F14902F75B9 Q28973610-60EB50E5-20FF-4EE0-80B7-C32DB2F0A0C3 Q30434991-7F08C43E-1330-4181-BA2E-E5FCF8A38870 Q30450150-7936DAAE-7C2A-4DB2-A227-CBAF5A4C9074 Q30493158-8AE2D223-936F-4305-A2D0-399BD939B28A Q30540950-7A34B46C-3E6A-4D96-A0D9-C51C5EC17832 Q30557598-05A75630-7042-44D9-82F6-24DB8BBBD90D Q30574128-07B4F8BE-7BD3-48D2-8E6B-33C0486A6B74 Q30601106-A5F3AC20-4B21-4BC5-8A13-C79CED884E0A Q30650955-A12E839A-578A-4A31-9B46-539B10EEC762 Q31125144-463E6956-9E76-4234-B711-E97E2169C846 Q33279531-81556CEE-A636-4D09-946B-DF7B9F269C22 Q33386030-F1535D87-5104-4259-91D9-F4C7CE754973 Q33555259-EFF09667-7A81-4A3A-AAF8-76769ABAAD41 Q33586940-93F3068E-74E4-457C-8EF6-82ED730168CA Q33631705-161D4523-7B46-4A91-B4CB-A1F93854E397 Q33637667-C32078A4-1A52-4E07-9DF5-CE3CF778B6A7 Q33654734-9FCE8D51-3ADA-49F2-A3A8-D021C18DA747 Q33713348-0E6DDD62-5EA4-4FD8-B9AC-B6BB795255E4

P2860

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors.

http://www.wikidata.org/entity/Q40692830

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Production and purification of ...... deno-associated viral vectors.

@en

type

label

Production and purification of ...... deno-associated viral vectors.

@en

prefLabel

Production and purification of ...... deno-associated viral vectors.

@en

P1433

Q40692830-0BF00D61-F91C-496F-9B64-87E0DC263F42

P1476

Q40692830-BF2183AC-8964-40E2-B8B3-498B2B9B7817

P2093

Q40692830-274E185C-8F14-4FA6-B004-23D2A1B8A56F

Q40692830-29F81033-5216-4FC9-B5A7-ECDF819F8A50

Q40692830-439011D3-07BE-41C8-983C-CBE92CDB8F16

Q40692830-56BBCC03-D7B0-4049-8B31-9BA55E2A3650

Q40692830-8E024535-C291-4896-8E49-82B80E7CBAAB

Q40692830-8E3F7A49-37B7-496F-8D97-7BDD48996556

Q40692830-8F02E5ED-F794-4D23-B867-9BD041958389

Q40692830-8F74E92C-DA15-4AAD-A0A5-49FD051542B4

Q40692830-970CF9AF-6263-4D65-9856-1E0ACCEFD0AA

Q40692830-9DCB22B9-E260-41DE-A266-FBF0BDDEE34E

P304

Q40692830-9F3454A9-2BE4-4785-801D-1F59BD1CA84C

P31

Q40692830-52102C55-6FE3-4D30-B833-E7006C91AA6B

P356

Q40692830-9EB4547A-83BC-4430-8CA1-9A2832E2C401

P433

Q40692830-452A428D-9FDC-42CA-BA02-D49006C99222

P478

Q40692830-3CD25D71-463A-47A1-90D3-A1B64ACF7805

P577

Q40692830-F9E4EF61-5275-4A6E-9DBB-3E6741D46CFC

P698

Q40692830-593A21A2-4BA1-4C9E-9800-A622F8FF9B04

P356

S1046-2023(02)00220-7

P1433

P1476

Production and purification of ...... deno-associated viral vectors.

@en

P2093

Barry J Byrne

http://www.w3.org/2001/XMLSchema#string

Irene Zolotukhin

http://www.w3.org/2001/XMLSchema#string

Mark Potter

http://www.w3.org/2001/XMLSchema#string

Nicholas Muzyczka

http://www.w3.org/2001/XMLSchema#string

Richard O Snyder

http://www.w3.org/2001/XMLSchema#string

Scott Loiler

http://www.w3.org/2001/XMLSchema#string

Sergei Zolotukhin

http://www.w3.org/2001/XMLSchema#string

Terance R Flotte

http://www.w3.org/2001/XMLSchema#string

Thomas J Fraites

http://www.w3.org/2001/XMLSchema#string

Tina Phillipsberg

http://www.w3.org/2001/XMLSchema#string

P304

158-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1046-2023(02)00220-7

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12413414

http://www.w3.org/2001/XMLSchema#string